PHARMACY

Hikma has introduced mitomycin for injection, a cancer treatment that had a market value of roughly $43 million for the year ended November 2018, according to IQVIA data.

NCPA's efforts to build support for parts of the Center for Medicare and Medicaid Services' drug pricing rule involving DIR fees has drawn wide support among pharmacists and stakeholders.

NACDS highlighted the role of pharmacists in its recommendations for the Department of Health and Human Services' Healthy People 2030 initiative.

An average of 54 new active substance launches per year are expected over the next five years, and two-thirds of launches will be specialty products, lifting specialty share of spending to near 50% by 2023 in most developed markets, the report said.

Health Mart's new president Nimesh Jhaveri has more than 30 years’ experience in the pharmacy business, having started as a pharmacy technician at Walgreens as an undergraduate. He joined the organization on Oct. 31.

As it marks a century in business, Upsher-Smith said its plans include diversifying and expanding its portfolio.

The Food and Drug Administration’s approval of Dr. Reddy's Tosymra provides a nasal spray for the acute treatment of migraine.

The Center for Medicare and Medicaid Services’ proposed changes to protected drug classes would jeopardize coverage for beneficiaries, according to PhRMA’s comments on the agency’s proposed rule.